• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004-2016 年伴有和不伴有糖尿病的慢性冠状动脉综合征患者的心血管风险。

Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016.

机构信息

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N, Denmark.

Department of Cardiology, Odense University Hospital, Odense, Denmark.

出版信息

BMC Cardiovasc Disord. 2021 Dec 4;21(1):579. doi: 10.1186/s12872-021-02312-y.

DOI:10.1186/s12872-021-02312-y
PMID:34863111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8642966/
Abstract

BACKGROUND

It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are present following the diagnosis of chronic coronary syndrome. The purpose of this study was to examine the change in cardiovascular risk among diabetes patients with chronic coronary syndrome from 2004 to 2016.

METHODS

We included patients with documentation of coronary artery disease by coronary angiography between 2004 and 2016 in Western Denmark. Patients were stratified by year of index coronary angiography (2004-2006, 2007-2009, 2010-2012, and 2013-2016) and followed for two years. The main outcome was major adverse cardiovascular events (MACE) defined as myocardial infarction, ischemic stroke, or death. Analyses were performed separately in patients with and without diabetes. We estimated two-year risk of each outcome and adjusted incidence rate ratios (aIRR) using patients examined in 2004-2006 as reference.

RESULTS

Among 5931 patients with diabetes, two-year MACE risks were 8.4% in 2004-2006, 8.5% in 2007-2009, and then decreased to 6.2% in 2010-2012 and 6.7% in 2013-2016 (2013-2016 vs 2004-2006: aIRR 0.70, 95% CI 0.53-0.93). In comparison, 23,540 patients without diabetes had event rates of 6.3%, 5.2%, 4.2%, and 3.9% for the study intervals (2013-2016 vs 2004-2006: aIRR 0.57, 95% CI 0.48-0.68).

CONCLUSIONS

Between 2004 and 2016, the two-year relative risk of MACE decreased by 30% in patients with diabetes and chronic coronary syndrome, but slightly larger absolute and relative reductions were observed in patients without diabetes.

摘要

背景

最近的研究表明,1996 年至 2011 年期间,新发糖尿病患者且无既往心血管疾病史者发生不良心血管事件的风险显著降低。然而,在诊断为慢性冠状动脉综合征后是否存在类似的改善尚不清楚。本研究旨在探讨 2004 年至 2016 年间患有慢性冠状动脉综合征的糖尿病患者心血管风险的变化。

方法

我们纳入了 2004 年至 2016 年期间在丹麦西部通过冠状动脉造影确诊为冠心病的患者。患者按索引冠状动脉造影年份分层(2004-2006 年、2007-2009 年、2010-2012 年和 2013-2016 年),随访两年。主要终点是主要不良心血管事件(MACE),定义为心肌梗死、缺血性卒中和死亡。分别在有和无糖尿病的患者中进行分析。我们估计了每种结局的两年风险,并使用 2004-2006 年检查的患者作为参考,调整了发病率比(aIRR)。

结果

在 5931 名患有糖尿病的患者中,2004-2006 年、2007-2009 年和 2010-2012 年的两年 MACE 风险分别为 8.4%、8.5%和 6.2%,而 2013-2016 年的风险降至 6.7%(2013-2016 年与 2004-2006 年相比:aIRR 0.70,95%CI 0.53-0.93)。相比之下,23540 名无糖尿病的患者在研究期间的事件发生率分别为 6.3%、5.2%、4.2%和 3.9%(2013-2016 年与 2004-2006 年相比:aIRR 0.57,95%CI 0.48-0.68)。

结论

2004 年至 2016 年间,患有糖尿病和慢性冠状动脉综合征的患者发生 MACE 的两年相对风险降低了 30%,但无糖尿病患者的绝对和相对降幅更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743f/8642966/6e74f6bc975c/12872_2021_2312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743f/8642966/9743543e81d9/12872_2021_2312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743f/8642966/6e74f6bc975c/12872_2021_2312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743f/8642966/9743543e81d9/12872_2021_2312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743f/8642966/6e74f6bc975c/12872_2021_2312_Fig2_HTML.jpg

相似文献

1
Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016.2004-2016 年伴有和不伴有糖尿病的慢性冠状动脉综合征患者的心血管风险。
BMC Cardiovasc Disord. 2021 Dec 4;21(1):579. doi: 10.1186/s12872-021-02312-y.
2
Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study.无阻塞性冠状动脉疾病的糖尿病患者的十年心血管风险:一项回顾性的丹麦西部队列研究。
Cardiovasc Diabetol. 2021 Jan 21;20(1):23. doi: 10.1186/s12933-021-01212-x.
3
Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry.在没有冠状动脉疾病的患者中,糖尿病不是心肌梗死的危险因素:来自丹麦西部心脏登记研究。
Diab Vasc Dis Res. 2020 Jul-Aug;17(4):1479164120941809. doi: 10.1177/1479164120941809.
4
Statin but not aspirin treatment is associated with reduced cardiovascular risk in patients with diabetes without obstructive coronary artery disease: a cohort study from the Western Denmark Heart Registry.他汀类药物治疗而非阿司匹林治疗与无阻塞性冠状动脉疾病的糖尿病患者心血管风险降低相关:来自丹麦西部心脏登记处的队列研究。
Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):434-441. doi: 10.1093/ehjcvp/pvab040.
5
Risk stratification by assessment of coronary artery disease using coronary computed tomography angiography in diabetes and non-diabetes patients: a study from the Western Denmark Cardiac Computed Tomography Registry.使用冠状动脉计算机断层扫描血管造影术对糖尿病和非糖尿病患者进行冠状动脉疾病风险分层:来自丹麦西部心脏计算机断层扫描登记处的一项研究。
Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1271-1278. doi: 10.1093/ehjci/jez010.
6
Thirteen-year trends in cardiovascular risk in men and women with chronic coronary syndrome.慢性冠状动脉综合征患者中男性和女性心血管风险的 13 年趋势。
Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):437-446. doi: 10.1093/ehjqcco/qcab015.
7
Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment.在接受适当预防治疗的真实世界人群中,患有糖尿病但无明显冠状动脉疾病的患者与无糖尿病患者发生心肌梗死的风险相同。
Diabetes Care. 2017 Aug;40(8):1103-1110. doi: 10.2337/dc16-2388. Epub 2017 Jun 8.
8
Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome.多支血管病变合并急性冠脉综合征患者代谢综合征的患病率及影响。
Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2693-2699. doi: 10.1016/j.numecd.2021.05.029. Epub 2021 Jun 5.
9
Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.甘油三酯-葡萄糖指数预测糖尿病合并急性冠脉综合征患者的不良心血管事件。
Cardiovasc Diabetol. 2020 Jun 13;19(1):80. doi: 10.1186/s12933-020-01054-z.
10
Poor long-term outcomes in stroke patients with asymptomatic coronary artery disease in heart CT.心脏 CT 检查中无症状性冠状动脉疾病的卒中患者预后不良。
Atherosclerosis. 2017 Oct;265:7-13. doi: 10.1016/j.atherosclerosis.2017.07.029. Epub 2017 Jul 29.

引用本文的文献

1
A systematic review and meta-analysis of the effect of hyperglycemia on admission for acute myocardial infarction in diabetic and non-diabetic patients.一项关于高血糖对糖尿病和非糖尿病患者急性心肌梗死入院影响的系统评价和荟萃分析。
Diabetol Metab Syndr. 2024 Sep 12;16(1):224. doi: 10.1186/s13098-024-01459-w.
2
Impact of type 2 diabetes on complications after primary breast cancer surgery: Danish population-based cohort study.2 型糖尿病对原发性乳腺癌手术后并发症的影响:丹麦基于人群的队列研究。
Br J Surg. 2024 Mar 2;111(3). doi: 10.1093/bjs/znae072.

本文引用的文献

1
Nationwide Trends in Cardiac Risk and Mortality in Patients With Incident Type 2 Diabetes: A Danish Cohort Study.初发2型糖尿病患者心脏风险及死亡率的全国性趋势:一项丹麦队列研究
Diabetes Care. 2021 Aug 11. doi: 10.2337/dc21-0383.
2
Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry.在没有冠状动脉疾病的患者中,糖尿病不是心肌梗死的危险因素:来自丹麦西部心脏登记研究。
Diab Vasc Dis Res. 2020 Jul-Aug;17(4):1479164120941809. doi: 10.1177/1479164120941809.
3
A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation.
一种用于预测非心房颤动患者血栓栓塞和心血管事件的新模型。
Am J Cardiol. 2020 Sep 15;131:40-48. doi: 10.1016/j.amjcard.2020.06.031. Epub 2020 Jun 28.
4
Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent Trials.稳定型缺血性心脏病血运重建后的长期结局:19 项随机冠状动脉支架置入试验的个体患者水平汇总分析。
Circ Cardiovasc Interv. 2020 Apr;13(4):e008565. doi: 10.1161/CIRCINTERVENTIONS.119.008565. Epub 2020 Apr 13.
5
10. Cardiovascular Disease and Risk Management: .10. 心血管疾病与风险管理: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S111-S134. doi: 10.2337/dc20-S010.
6
Ten-Year Outcomes of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stents in Patients With Versus Without Diabetes Mellitus (SORT OUT III).西罗莫司洗脱支架与佐他莫司洗脱支架治疗合并或不合并糖尿病患者的 10 年结果(SORT OUT III)。
Am J Cardiol. 2020 Feb 1;125(3):349-353. doi: 10.1016/j.amjcard.2019.10.042. Epub 2019 Nov 7.
7
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin.冠状动脉周围脂肪炎症与糖尿病前期急性心肌梗死患者的主要不良心脏事件(MACE):二甲双胍的作用。
Cardiovasc Diabetol. 2019 Sep 30;18(1):126. doi: 10.1186/s12933-019-0931-0.
8
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
9
Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study.二甲双胍治疗对稳定型心绞痛伴非阻塞性冠状动脉狭窄的糖尿病前期患者冠状动脉内皮功能障碍的影响:CODYCE 多中心前瞻性研究。
Diabetes Care. 2019 Oct;42(10):1946-1955. doi: 10.2337/dc18-2356. Epub 2019 Feb 22.
10
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.过去 20 年中,非 ST 段抬高型心肌梗死患者新治疗方法的实施与改善结局之间的关系:来自 SWEDEHEART 注册研究 1995 至 2014 年的经验。
Eur Heart J. 2018 Nov 7;39(42):3766-3776. doi: 10.1093/eurheartj/ehy554.